|
WO2021072378A1
|
|
An automatic approach to establish dental occlusion for 1-piece, 2-piece, and 3-piece maxillary orthognathic surgeries
|
|
WO2020206135A1
|
|
Image-based methods for estimating a patient-specific reference bone model for a patient with a craniomaxillofacial defect and related systems
|
|
WO2020113055A1
|
|
Customizable helical telescoping internal craniofacial distractor
|
|
WO2020060997A1
|
|
Signal isolation magnetic resonance image (simri) and methods thereof
|
|
WO2020036646A2
|
|
Cancer neoantigens and their utilities in cancer vaccines and tcr-based cancer immunotherapy
|
|
WO2019200216A1
|
|
Modulation of irf-4 and uses thereof
|
|
US2020405763A1
|
|
Irf-4 engineered t cells and uses thereof in treating cancer
|
|
WO2019094698A1
|
|
Neurostimulation induced medicine devices and related methods of use
|
|
EP3697469A1
|
|
Delivery devices
|
|
EP3634410A1
|
|
Tau phosphorylation inhibitors and methods for treating or preventing alzheimer's disease
|
|
US2019010533A1
|
|
Methods for screening and selecting target agents from molecular databases
|
|
GB201904737D0
|
|
PD-1 specific aptamers
|
|
EP3500172A1
|
|
Systems and methods for computer-aided orthognathic surgical planning
|
|
WO2017165614A1
|
|
Pre-transplant tcr clonality assessment to predict post-liver transplant survival
|
|
EP3422927A1
|
|
System and method using cardiac-esophageal impedance mapping to predict and detect esophageal injury during cardiac ablation procedures
|
|
US2019048342A1
|
|
Cross-regulation of type i interferon signaling pathways
|
|
EP3380102A1
|
|
Telomere extension and anti-inflammatory agents for cell regeneration
|
|
WO2017070196A1
|
|
Cellular vectors for delivery of therapeutics
|
|
WO2016187100A1
|
|
Implantable nanochannel delivery devices
|
|
WO2016164743A2
|
|
Cd38 ligand-drug conjugates for targeted cancer therapy
|
